Clinical trial

Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients

NCT04059770

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention single dose of L-AmB Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 2 doses of L-AmB Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 2 weeks of L-AmB Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-02-14

PhasePHASE2

Conditions

Histoplasmosisverified · MONDO: histoplasmosis

AIDSverified · MONDO: AIDS

Interventions

single dose of L-AmBDRUG

2 doses of L-AmBDRUG

2 weeks of L-AmBDRUG

Sponsors & collaborators

Alessandro Pasqualottolead sponsor

Hospital de Clinicas de Porto Alegrecollaborator

Hospital Nossa Senhora da Conceicaocollaborator

Irmandade Santa Casa de Misericórdia de Porto Alegrecollaborator

Mapped research locations

Porto AlegreRio Grande do Sul, Brazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04059770 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.